[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637174":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":56,"collaborators":26,"id":59,"slug":26,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":26,"enrollmentInfo":68,"targetDuration":26,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":26,"overallStatus":42,"whyStopped":26,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"University of Saskatchewan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Creatine","EXPERIMENTAL","10 grams per day creatine",[13],"Dietary Supplement: Dietary supplementation during a 12 week resistance-training program (creatine)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Placebo (maltodextrin)",[19],"Dietary Supplement: Dietary supplementation during a 12 week resistance-training program (placebo)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Dietary supplementation during a 12 week resistance-training program (creatine)","creatine supplementation",[9],null,{"type":22,"name":28,"description":15,"armGroupLabels":29,"otherNames":26},"Dietary supplementation during a 12 week resistance-training program (placebo)",[15],[31],{"name":32,"affiliation":5,"role":33},"Philip Chilibeck, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},"Philip D Chilibeck, PhD","CONTACT","306-966-1072","phil.chilibeck@usask.ca",[41],{"facility":5,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"RECRUITING","Saskatoon","SK - Saskatchewan","S7N 5B2","Canada","CA",{"type":49,"coordinates":50},"Point",[51,52],-106.66892,52.13238,{"lat":52,"lon":51},[55],{"name":36,"role":37,"phone":38,"phoneExt":26,"email":39},{"type":33,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Phil Chilibeck","Professor","100637174",false,"NCT07625202","Creatine Supplementation During GLP-1a Therapy","A Pilot Study on Creatine Supplementation During Resistance-training for Prevention of Lean Tissue Mass Loss During GLP-1 Receptor Agonist Therapy","Inclusion Criteria:\n\n* Starting GLP-1 agonist therapy\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)",true,"ALL","18 Years",{"count":69,"type":70},40,"ESTIMATED","INTERVENTIONAL",[73],"NA","GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.",[76],"Sarcopenia","2026-05-30",{"date":79,"type":80},"2026-06-04","ACTUAL",{"date":82,"type":80},"2026-05-25",{"date":84,"type":70},"2027-12-31",{"name":5,"class":6},1]